A human gut microbial gene catalogue established by ,
URL : https://hal.archives-ouvertes.fr/cea-00908974
Enhanced Th1 activity and development of chronic 1 enterocolitis in mice devoid of Stat3 in macrophages and neutrophils, Immunity, vol.10, p.49, 1999. ,
SCFAs Induce Mouse Neutrophil 4 Chemotaxis through the GPR43 Receptor, PloS one, vol.6, 2011. ,
Effects of short chain fatty acids on 6 effector mechanisms of neutrophils, Cell Biochem Funct, vol.27, pp.48-55, 2009. ,
Evaluation of the effects of short-chain fatty 8 acids and extracellular pH on bovine neutrophil function in vitro, Am J Vet Res, vol.67, p.1907, 2006. ,
Short-chain fatty acids produced by anaerobic 11 bacteria inhibit phagocytosis by human lung phagocytes, J Infect Dis, vol.161, pp.138-142, 1990. ,
Short-chain fatty acids induce pro-13 inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am 14, J Reprod Immunol, vol.67, pp.391-400, 2012. ,
Effect of sodium butyrate on reactive oxygen species 16 generation by human neutrophils, Scand J Gastroenterol, vol.36, pp.744-750, 2001. ,
Butyrate and propionate induced activated or non-18 activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-19 ,
, GPR-43 pathways, Nutrition, vol.26, pp.653-661, 2010.
Neutrophil apoptosis mediated by nicotinic acid 21 receptors (GPR109A), Cell Death Differ, vol.15, pp.134-142, 2008. ,
Butyrate suppresses murine mast cell proliferation and 23 cytokine production through inhibiting histone deacetylase, J Nutr Biochem, vol.27, pp.299-306, 2016. ,
Effect of sodium butyrate on lymphocyte activation ,
, J Exp Med, vol.144, pp.1674-1678, 1976.
Histone deacetylase inhibitor uses p21(Cip1) to 27 maintain anergy in CD4+ T cells, Int Immunopharmacol, vol.9, pp.1289-1297, 2009. ,
Chemical Inducers of Differentiation in Friend-29 ,
, Leukemia Cells Inhibit Lymphocyte Mitogenesis, Nature, vol.285, pp.106-108, 1980.
Th1 cell anergy and blockade in G1a phase of the cell cycle, J 31 Immunol, vol.151, pp.1245-1254, 1993. ,
The histone deacetylase inhibitor Trichostatin A 33 modulates CD4+ T cell responses, Bmc Cancer, vol.3, p.30, 2003. ,
Characterization of the effects of 35 butyric acid on cell proliferation, cell cycle distribution and apoptosis, FEMS Immunol Med, p.36 ,
, , vol.47, pp.67-74, 2006.
n-butyrate downregulates the stimulatory 38 function of peripheral blood-derived antigen-presenting cells: a potential mechanism for 39 modulating T-cell responses by short-chain fatty acids, Immunology, vol.92, pp.234-243, 1997. ,
Cutting Edge: Distinct Glycolytic and Lipid 41 ,
, Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4(+) T Cell 42 Subsets, Journal of Immunology, vol.186, pp.3299-3303, 2011.
Inhibitory effect of tumor cell-derived lactic acid 44 on human T cells, Blood, vol.109, pp.3812-3819, 2007. ,
The specific monocarboxylate transporter (MCT1) 46 inhibitor, AR-C117977, a novel immunosuppressant ,
, Transplantation, vol.84, pp.1204-1207, 2007.
Butyric acid-induced T-cell apoptosis is 1 mediated by caspase-8 and-9 activation in a Fas-independent manner, Clin Diagn Lab Immun, vol.2, pp.325-332, 2001. ,
Butyrate in vitro immune-modulatory effects 4 might be mediated through a proliferation-related induction of apoptosis, Immunobiology, vol.5, pp.863-873, 2010. ,
Commensal microbe-derived butyrate induces the 7 differentiation of colonic regulatory T cells, Nature, vol.504, p.446, 2013. ,
Inhibition of interferon gamma signaling by the 9 short chain fatty acid butyrate, Mol Cancer Res, vol.1, pp.855-862, 2003. ,
Essential role of the JAK/STAT1 signaling 11 pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its 12 regulation by butyrate, J Biol Chem, vol.282, pp.9797-9804, 2007. ,
Short-chain fatty acid derivatives 14 stimulate cell proliferation and induce STAT-5 activation, Blood, vol.97, pp.3259-3267, 2001. ,
Induction of anergy in Th1 cells associated with 16 increased levels of cyclin-dependent kinase inhibitors p21(Cip1) and p27(Kip1), Journal of 17 Immunology, vol.166, pp.952-958, 2001. ,
The ability of antigen, but not interleukin-2, to 19 promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and 20 altered association patterns of cyclin-dependent kinase inhibitors, Immunology, vol.106, p.495, 2002. ,
Butyrate inhibits interleukin-17 and generates Tregs 23 to ameliorate colorectal colitis in rats, BMC Gastroenterol, vol.16, p.84, 2016. ,
Comparative Analysis of Protocols to Induce 25 Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, 26 Rapamycin and Butyrate, PloS one, vol.11, p.148474, 2016. ,
Effects of short chain fatty acids and GPR43 28 stimulation on human Treg function, The Journal of Immunology, vol.194, pp.58-72, 2015. ,
Short-Chain Fatty Acids Regulate 30 Cytokines and Th17/Treg Cells in Human Peripheral Blood Mononuclear Cells in vitro ,
, Immunol Invest, vol.2016, pp.1-18
Foxp3(+) T cells expressing RORgammat 33 represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during 34 intestinal inflammation, Mucosal immunology, vol.9, pp.444-457, 2016. ,
CD4+ regulatory T cells control TH17 responses 36 in a Stat3-dependent manner, Science, vol.326, pp.986-991, 2009. ,
Foxp3 occupancy and regulation of key 38 target genes during T-cell stimulation, Nature, vol.445, pp.931-935, 2007. ,
Using histone deacetylase inhibitors to enhance ,
, Foxp3(+) regulatory T-cell function and induce allograft tolerance, Immunol Cell Biol, vol.41, pp.195-202, 2009.
Combination of isoform-selective histone/protein 43 deacetylase inhibitors improves Foxp3+T-regulatory cell function, Cell Cycle, vol.11, p.3352, 2012. ,
CD4 T cell anergy prevents autoimmunity 46 and generates regulatory T cell precursors, Nat Immunol, 2016. ,
DOI : 10.1038/ni.3331
URL : http://europepmc.org/articles/pmc4755884?pdf=render
HIF1alpha-dependent glycolytic pathway orchestrates a 48 metabolic checkpoint for the differentiation of TH17 and Treg cells, J Exp Med, vol.49, pp.1367-1376, 2011. ,
IL-35-producing B cells are critical regulators of 1 immunity during autoimmune and infectious diseases, Journal of leukocyte biology, vol.507, pp.461-469, 2014. ,
Specific immunotherapy in combination with Clostridium 5 butyricum inhibits allergic inflammation in the mouse intestine, Sci Rep, vol.5, 2015. ,
Clostridium butyricum in combination with specific 7 immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients, Sci 8 Rep, vol.6, p.20481, 2016. ,
Multiple regulatory mechanisms control B-1 B cell activation ,
DOI : 10.3389/fimmu.2012.00372
URL : https://www.frontiersin.org/articles/10.3389/fimmu.2012.00372/pdf
, Front Immunol, vol.3, p.372, 2012.
Regulatory T cells reinforce intestinal homeostasis, Immunity, vol.12, pp.401-411, 2009. ,
DOI : 10.1016/j.immuni.2009.08.011
URL : https://doi.org/10.1016/j.immuni.2009.08.011
MS-275, an histone deacetylase inhibitor, reduces 14 the inflammatory reaction in rat experimental autoimmune neuritis, Neuroscience, vol.15, pp.370-377, 2010. ,
Butyrate enhances antibacterial effects while 17 suppressing other features of alternative activation in IL-4-induced macrophages, Am J Physiol 18 Gastrointest Liver Physiol, 2016. ,
Microbial metabolite butyrate facilitates M2 macrophage 20 polarization and function, Sci Rep, vol.6, p.24838, 2016. ,
DOI : 10.1038/srep24838
URL : https://www.nature.com/articles/srep24838.pdf
CD4(+)CD25(+)Foxp3(+) regulatory T cells 22 induce alternative activation of human monocytes/macrophages, P Natl Acad Sci, vol.23, pp.19446-19451, 2007. ,
HDAC inhibitors TSA and sodium butyrate enhanced the 25 human IL-5 expression by altering histone acetylation status at its promoter region, Immunol 26 Lett, vol.108, pp.143-150, 2007. ,
Tolerogenic Dendritic Cells for Regulatory T 28, Cell Induction in Man. Front Immunol, vol.6, 2015. ,
Diet-Derived Short Chain Fatty Acids Stimulate 30 Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic Cells, Immunology, vol.198, pp.2172-2181, 2017. ,
The SCFA butyrate stimulates the epithelial 33 production of retinoic acid via inhibition of epithelial HDAC, Am J Physiol Gastrointest Liver, vol.34 ,
, Transforming Growth Factor-beta, vol.36
, Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands, Immunity, vol.37, p.38, 2016.
Transforming growth factor-beta and 39 Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate 40 lymphoid cells, Sci Signal, vol.9, p.46, 2016. ,
Metabolites from commensal microbes are closely associated 42 with maintaining mucosal homeostasis through modulation of innate lymphoid cells in Peyer's 43 patch, Journal of Immunology, vol.192, pp.133-125, 2014. ,
GATA3 controls Foxp3(+) regulatory T 45 cell fate during inflammation in mice, J Clin Invest, vol.121, pp.4503-4515, 2011. ,
GATA3-driven Th2 responses inhibit TGF-beta1-47 induced FOXP3 expression and the formation of regulatory T cells, Plos Biol, vol.5, p.329, 2007. ,
Faecalibacterium prausnitzii is an anti-1 inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease 2 patients, P Natl Acad Sci USA, vol.105, pp.16731-16736, 2008. ,
Characterization of the gastrointestinal microbiota 4 in health and inflammatory bowel disease, Inflamm Bowel Dis, vol.18, pp.372-390, 2012. ,
Twin Study Indicates Loss of Interaction 6 Between Microbiota and Mucosa of Patients With Ulcerative Colitis, Gastroenterology, vol.7, pp.227-236, 2011. ,
Role of the gut microbiota in immunity and 9 inflammatory disease, Nat Rev Immunol, vol.13, pp.321-335, 2013. ,
The Impact of the Gut Microbiota on Human 11 Health: An Integrative View, Cell, vol.148, pp.1258-1270, 2012. ,
Recent trends in the epidemiology of inflammatory bowel diseases: up or 13 down?, World J Gastroenterol, vol.12, pp.6102-6108, 2006. ,
Mechanisms of Disease Inflammatory Bowel Disease, New Engl J 15 Med, vol.361, pp.2066-2078, 2009. ,
The genetics and immunopathogenesis of inflammatory bowel disease, Nat Rev 17 Immunol, vol.8, pp.458-466, 2008. ,
Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, vol.19, pp.182-205, 1998. ,
DOI : 10.1111/jgh.12751
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.12751
Increased expression of interleukin 17 in inflammatory 21 bowel disease, Gut, vol.52, pp.65-70, 2003. ,
Synergy between intraepithelial lymphocytes and 23 lamina propria T cells drives intestinal inflammation during infection, Mucosal immunology, vol.24, pp.658-670, 2011. ,
DOI : 10.1038/mi.2011.31
URL : https://www.nature.com/articles/mi201131.pdf
Intestinal inflammation abrogates the tolerogenic 26 properties of MLN CD103(+) dendritic cells, Eur J Immunol, vol.40, pp.1877-1883, 2010. ,
Monocyte-derived dendritic cells activated by 28 bacteria or by bacteria-stimulated epithelial cells are functionally different, Blood, vol.29, pp.2818-2826, 2005. ,
Mast cells as modulators of T-cell responses, Immunol Rev, vol.31, pp.53-64, 2007. ,
, The Transcription Factor T-bet Regulates 33 Intestinal Inflammation Mediated by Interleukin-7 Receptor(+) Innate Lymphoid Cells
, Immunity, vol.37, pp.674-684, 2012.
Nod/Ripk2 signaling in dendritic cells activates 36 IL-17A-secreting innate lymphoid cells and drives colitis in T-bet ,
, P Natl Acad Sci USA, vol.111, pp.2559-2566, 2014.
Innate lymphoid cells drive interleukin-23-39 dependent innate intestinal pathology, Nature, vol.464, pp.1371-1375, 2010. ,
Human type 1 innate lymphoid cells accumulate 41 in inflamed mucosal tissues, Nat Immunol, vol.14, pp.221-229, 2013. ,
IL-23-responsive innate 43 lymphoid cells are increased in inflammatory bowel disease, J Exp Med, vol.208, pp.1127-1133, 2011. ,
Peripheral monocyte and naive T-cell recruitment 45 and activation in Crohn's disease, Gastroenterology, vol.109, pp.1029-1038, 1995. ,
Differential expression of CD25 47 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in 48 Crohn's disease and ulcerative colitis, Gut, vol.31, pp.1365-1370, 1990. ,
Expression of gamma delta T lymphocytes derived 1 from human intestinal biopsies, Immunol Res, vol.10, pp.310-312, 1991. ,
Immunohistochemical characterization, 3 distribution, and ultrastructure of lymphocytes bearing T-cell receptor gamma/delta in 4 inflammatory bowel disease, Gastroenterology, vol.101, pp.670-678, 1991. ,
Changes in human mucosal gamma delta 6 T cell repertoire and function are associated with the disease process in inflammatory bowel 7 disease, Gastroenterology, vol.112, pp.1038-1038, 1997. ,
Chemokines as Novel Therapeutic Targets for 9 Inflammatory Bowel Disease, Ann Ny Acad Sci, vol.1173, pp.350-356, 2009. ,
CCR9-positive lymphocytes and thymus-11 expressed chemokine distinguish small bowel from colonic Crohn's disease, Gastroenterology, vol.12, pp.246-254, 2001. ,
Microbiota-Dependent Sequelae of Acute Infection 14 Compromise Tissue-Specific Immunity, Cell, vol.163, pp.354-366, 2015. ,
Acute Gastrointestinal Infection Induces 16 Long-Lived Microbiota-Specific T Cell Responses, Science, vol.337, pp.1553-1556, 2012. ,
Genetic and Metabolic Signals during Acute Enteric 18 Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory 19 Disease, Cell Host Microbe, vol.19, pp.21-31, 2016. ,
Disease Phenotype and Genotype Are 21 Associated with Shifts in Intestinal-associated Microbiota in Inflammatory Bowel Diseases ,
, Inflamm Bowel Dis, vol.17, pp.179-184, 2011.
Molecular-phylogenetic characterization of 24 microbial community imbalances in human inflammatory bowel diseases. P Natl Acad Sci 25 USA, vol.104, pp.13780-13785, 2007. ,
Reduction in diversity of the colonic mucosa 27 associated bacterial microflora in patients with active inflammatory bowel disease, Gut, vol.28, pp.685-693, 2004. ,
Dysfunction of the intestinal microbiome in 30 inflammatory bowel disease and treatment, Genome Biol, vol.13, 2012. ,
Reduction of butyrate-and methane-producing 32 microorganisms in patients with, Irritable Bowel Syndrome. Sci Rep, vol.5, p.12693, 2015. ,
Colonisation by Faecalibacterium prausnitzii and 34 maintenance of clinical remission in patients with ulcerative colitis, Aliment Pharm Ther, vol.35, pp.151-161, 2013. ,
A decrease of the butyrate-producing species 37 Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with 38 ulcerative colitis, Gut, vol.63, pp.1275-1283, 2014. ,
Increased Proportions of Bifidobacterium and the 40 Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease ,
, J Clin Microbiol, vol.52, pp.398-406, 2014.
The Treatment-Naive Microbiome in New-43 Onset Crohn's Disease, Cell Host Microbe, vol.15, pp.382-392, 2014. ,
DOI : 10.1016/j.chom.2014.02.005
URL : https://doi.org/10.1016/j.chom.2014.02.005
Low Counts of Faecalibacterium prausnitzii in Colitis 45 Microbiota, Inflamm Bowel Dis, vol.15, pp.1183-1189, 2009. ,
Fecal Short-Chain Fatty-Acids in Children with 47 Inflammatory Bowel-Disease, J Pediatr Gastr Nutr, vol.18, pp.159-164, 1994. ,
Rapid and noninvasive metabonomic 49 characterization of inflammatory bowel disease, J Proteome Res, vol.6, pp.546-551, 2007. ,
DOI : 10.1021/pr060470d
Butyricicoccus pullicaecorum in inflammatory 1 bowel disease, Gut, vol.62, pp.1745-1752, 2013. ,
Deciphering bifidobacterial-mediated metabolic 3 interactions and their impact on gut microbiota by a multi-omics approach, Isme J, 2016. ,
DOI : 10.1038/ismej.2015.236
URL : https://www.nature.com/articles/ismej2015236.pdf
Treatment of diversion colitis with short-5 chain-fatty acid irrigation, N Engl J Med, vol.320, pp.23-28, 1989. ,
Treatment of distal ulcerative colitis with 7 short-chain fatty acid enemas -A placebo-controlled trial, Digest Dis Sci, vol.41, pp.2254-2259, 1996. ,
Effect of Butyrate Enemas on the Colonic 9 Mucosa in Distal Ulcerative-Colitis, Gastroenterology, vol.103, pp.51-56, 1992. ,
Rectal Irrigation with Short-Chain Fatty-Acids for ,
, Distal Ulcerative-Colitis -Preliminary-Report. Digest Dis Sci, vol.36, pp.185-187, 1991.
Down-regulation of the monocarboxylate 13 transporter 1 is involved in butyrate deficiency during intestinal inflammation ,
, Gastroenterology, vol.133, pp.1916-1927, 2007.
The probiotic Lactobacillus plantarum 16 counteracts TNF-{alpha}-induced downregulation of SMCT1 expression and function, Am J 17 Physiol Gastrointest Liver Physiol, vol.299, pp.928-934, 2010. ,
Gut microbiome-derived metabolites modulate 19 intestinal epithelial cell damage and mitigate graft-versus-host disease, Nat Immunol, vol.20, pp.505-518, 2016. ,
DOI : 10.1038/ni.3400
URL : http://europepmc.org/articles/pmc4836986?pdf=render
Peripheral and intestinal regulatory 22 CD4+CD25(high) T cells in inflammatory bowel disease, Gastroenterology, vol.128, p.1878, 2005. ,
Functional CD4+CD25high regulatory T cells 25 are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with 26 disease activity, Inflamm Bowel Dis, vol.12, pp.447-456, 2006. ,
Characterization of FOXP3(+)CD4(+) regulatory T 28 cells in Crohn's disease, Clin Immunol, vol.125, pp.281-290, 2007. ,
Stability of the Regulatory T Cell Lineage in 30 Vivo, Science, vol.329, pp.1667-1671, 2010. ,
TGF-beta-induced Foxp3 inhibits T(H)17 cell 32 differentiation by antagonizing RORgammat function, Nature, vol.453, pp.236-240, 2008. ,
DOI : 10.1038/nature06878
URL : https://www.nature.com/articles/nature06878.pdf
Alloantigen-specific de novo-induced Foxp3+ ,
DOI : 10.1002/eji.200939432
URL : https://hal.archives-ouvertes.fr/hal-00431886
, Treg revert in vivo and do not protect from experimental GVHD, Eur J Immunol, vol.35, pp.3091-3096, 2009.
Plasticity of human Th17 cells and iTregs 37 is orchestrated by different subsets of myeloid cells, Blood, vol.117, pp.6532-6541, 2011. ,
Histone acetyltransferase mediated regulation of FOXP3 39 acetylation and Treg function, Curr Opin Immunol, vol.22, pp.583-591, 2010. ,
DOI : 10.1016/j.coi.2010.08.013
URL : http://europepmc.org/articles/pmc2967626?pdf=render
Gut microbial metabolites limit the frequency 41 of autoimmune T cells and protect against type 1 diabetes, Mucosal immunology, vol.42, pp.210-214, 2014. ,
Donor Species Richness Determines Faecal 45 ,
DOI : 10.1093/ecco-jcc/jjv203
URL : https://academic.oup.com/ecco-jcc/article-pdf/10/4/387/13746252/jjv203.pdf
, Microbiota Transplantation Success in Inflammatory Bowel Disease, J Crohns Colitis, vol.46, pp.387-394, 2016.
The intracellular target of butyrate's actions: HDAC or HDON'T?, Gut, vol.48, pp.447-448, 2000. ,
Anticarcinogenic actions of tributyrin, a butyric 1 acid prodrug, Current drug targets, vol.13, pp.1720-1729, 2012. ,
Phase II trial of the histone deacetylase inhibitor 3 pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer, Lung 4 Cancer, vol.45, pp.381-386, 2004. ,
Preparation and evaluation of tributyrin emulsion as a 6 potent anti-cancer agent against melanoma, Drug Deliv, vol.18, pp.143-149, 2011. ,